We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.21%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$475M
(+9.3%)
Cap. Flow
+$41M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
897
New
106
Increased
245
Reduced
364
Closed
101
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IHS Markit Ltd. Common Shares
INFO
|
+$37.5M |
| 2 |
Charles Schwab
SCHW
|
+$25.3M |
| 3 |
Abbott
ABT
|
+$17.5M |
| 4 |
Blackstone
BX
|
+$14.7M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$46.3M |
| 2 |
Acuity Brands
AYI
|
+$34.4M |
| 3 |
SBA Communications
SBAC
|
+$30.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$18M |
| 5 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.99% |
| 2 | Financials | 15.82% |
| 3 | Technology | 14.83% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Alerian MLP ETF
AMLP
$12.5B
| $887K | 0.02% |
13,956
+2,292
| +20% | +$147K |
2013 Q2
15 quarters
|
|
352
Wintrust Financial
WTFC
$9.68B
| $886K | 0.02% |
12,819
+9,224
| +257% | +$663K |
2016 Q4
1 quarter
|
|
353
iShares Russell 1000 Growth ETF
IWF
$127B
| $885K | 0.02% |
31,120
+9,552
| +44% | +$265K |
2015 Q2
7 quarters
|
|
354
Weyerhaeuser
WY
$14B
| $873K | 0.02% |
25,688
-70
| -0.3% | -$2.28K |
2014 Q1
12 quarters
|
|
355
Parker-Hannifin
PH
$121B
| $872K | 0.02% |
5,438
+3
| +0.1% | +$455 |
2015 Q2
7 quarters
|
|
356
Applied Materials
AMAT
$341B
| $860K | 0.02% |
+22,099
| New | +$794K |
2017 Q1
0 quarters
|
|
|
CARB
357
DELISTED
Carbonite Inc
CARB
| $860K | 0.02% |
42,359
+2,134
| +5% | +$40.1K |
2015 Q2
7 quarters
|
|
358
Canadian Pacific Kansas City
CP
$76.4B
| $849K | 0.02% |
28,900
+470
| +2% | +$14K |
2013 Q4
13 quarters
|
|
359
Vanguard Morningstar Growth ETF
VUG
$232B
| $832K | 0.01% |
41,034
-3,276
| -7% | -$64.6K |
2015 Q4
5 quarters
|
|
|
LDL
360
DELISTED
Lydall, Inc.
LDL
| $832K | 0.01% |
15,523
-4,979
| -24% | -$282K |
2016 Q1
4 quarters
|
|
361
DELISTED
Hologic
HOLX
| $829K | 0.01% |
19,478
-4,332
| -18% | -$177K |
2014 Q1
12 quarters
|
|
362
Lazard
LAZ
$3.52B
| $829K | 0.01% |
18,020
-4,600
| -20% | -$198K |
2013 Q2
15 quarters
|
|
|
GG
363
DELISTED
Goldcorp Inc
GG
| $824K | 0.01% |
56,484
+5,071
| +10% | +$79.3K |
2015 Q3
6 quarters
|
|
364
iShares Global Energy ETF
IXC
$3.21B
| $814K | 0.01% |
24,510
| – | – |
2016 Q1
4 quarters
|
|
365
Snap-on
SNA
$18.9B
| $810K | 0.01% |
4,802
-76
| -2% | -$13.1K |
2015 Q2
7 quarters
|
|
366
Aflac
AFL
$59.2B
| $808K | 0.01% |
22,302
-108
| -0.5% | -$3.83K |
2013 Q4
13 quarters
|
|
367
Vanguard FTSE Europe ETF
VGK
$29.7B
| $803K | 0.01% |
15,569
-10,677
| -41% | -$533K |
2015 Q3
6 quarters
|
|
368
Anika Therapeutics
ANIK
$277M
| $802K | 0.01% |
+18,465
| New | +$881K |
2017 Q1
0 quarters
|
|
369
Duke Energy
DUK
$92.7B
| $801K | 0.01% |
9,761
-267
| -3% | -$21.2K |
2013 Q2
15 quarters
|
|
370
Goldman Sachs
GS
$260B
| $790K | 0.01% |
3,438
-636
| -16% | -$154K |
2015 Q4
5 quarters
|
|
|
BSTC
371
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $789K | 0.01% |
14,406
+293
| +2% | +$15.5K |
2014 Q1
12 quarters
|
|
372
Baxter International
BAX
$13.3B
| $786K | 0.01% |
15,154
-4,846
| -24% | -$238K |
2013 Q2
15 quarters
|
|
373
DELISTED
Dominion Diamond Corporation
DDC
| $766K | 0.01% |
60,650
+8,565
| +16% | +$86.5K |
2014 Q1
12 quarters
|
|
374
Woodward
WWD
$19.7B
| $757K | 0.01% |
11,143
+523
| +5% | +$36.2K |
2016 Q1
4 quarters
|
|
|
CLR
375
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $755K | 0.01% |
16,632
+7,557
| +83% | +$356K |
2013 Q2
15 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Geneva Advisors held 897 positions worth $5.6B, up 9.3% from $5.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geneva Advisors's Q1 2017 filing shows 106 new, 245 increased, 364 reduced and 101 closed positions. Its largest new stake was IHS Markit Ltd. Common Shares: 946,941 shares worth $39.7M. The largest sale was B/E Aerospace Inc, an estimated $46.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.
- Geneva Advisors's largest Q1 2017 buy was IHS Markit Ltd. Common Shares: 946,941 shares worth $39.7M.
- Geneva Advisors added most to Abbott in Q1 2017, an estimated $17.5M increase.
- Geneva Advisors's biggest Q1 2017 reduction was B/E Aerospace Inc, cutting an estimated $46.3M.
- Geneva Advisors fully exited NXP Semiconductors in Q1 2017, selling an estimated $5.02M.
- Geneva Advisors's ten largest holdings make up 26% of its $5.6B portfolio in Q1 2017.
- Geneva Advisors opened 106 new positions and closed 101 in Q1 2017.
- Geneva Advisors's portfolio value rose 9.3% quarter-over-quarter to $5.6B.
Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.